Saving changes...

Done

Error

Creation of Stereotactic Radiosurgery Target Volumes in Patients with Marginally Resected Tumors using Liquid Fiducial

Creation of Stereotactic Radiosurgery Target Volumes in Patients with Marginally Resected Tumors using Liquid Fiducial

Creation of Stereotactic Radiosurgery Target Volumes in Patients with Marginally Resected Tumors using Liquid Fiducial

Dr. Neal Mauldin
Dr. Neal Mauldin
on behalf of Missouri Veterinary Medical Association

$FREE $ FREE $ FREE

$ FREE $ FREE $ FREE
$ 25.00 $ 25.00 $ 25.00
Normal Price: FREE $25.00

Review:

Launch date: 01 Feb 2019
Expiry Date:

Last updated: 27 Feb 2019

Reference: 193381

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

This clinical trial evaluates the safety and effectiveness of a proprietary liquid fiducial, PetXMark®, in defining a post-resection clinical target volume (CTV) for patients with marginally resected tumors of the skin and subcutaneous tissues. This clinical target volume can then be used to define a planning target volume (PTV) for the purposes of delivering a single fraction of stereotactic radiation (SRS) to the resection bed as a form of curative intent therapy.

Objectives

Objectives
1. To become familiar with the use of liquid fiducials in the treatment of marginally resected tumors
2. To understand the utility, risks, and effectiveness of using SRS to treat target volumes created post resection using liquid fiducial
Dr. Neal Mauldin

Author Information Play Video Bio

Dr. Neal Mauldin
on behalf of Missouri Veterinary Medical Association

Veterinary Cancer Society Dr. Neal Mauldin
Dr. Neal Mauldin is a triple-board certified veterinarian in the specialty areas of internal medicine, oncology, and radiation oncology. He has been PetCure Oncology’s chief medical officer since 2014. In that role, Dr. Mauldin provides clinical oversight, remote treatment planning and review, and oversees clinical research across PetCure Oncology’s national network. He is also responsible for leadership of PetCure’s Scientific Advisory Board, an independent group of human and veterinary clinicians with expertise in radiation oncology, medical oncology, stereotactic radiation, and medical physics.
After achieving board certification in internal medicine in 1988 and medical oncology in 1989, Dr. Mauldin added radiation oncology in 1994 - the first year that board certification was offered in that field. More than two decades later, he has become known as one of the leading experts in radiation therapy for pets and a pioneer in the integration of stereotactic radiation (SRS/SRT) into veterinary medicine. Dr. Mauldin has treated more than 2,000 pets with SRS/SRT since 2010.
His professional experience includes 11 years at the Donaldson-Atwood Cancer Clinic of the Animal Medical Center in New York, eight years of clinical and educational work at Louisiana State University, and 10 years at Western Veterinary Specialist and Emergency Centre in Calgary, Alberta.

Dr. Mauldin has authored over 20 peer-reviewed publications and numerous textbook chapters pertaining to the specialty of veterinary oncology. He has presented invited scientific abstracts at over 40 national and international meetings, served on the residency training and examination committees for the specialties of medical and radiation oncology, and is a past president of the Veterinary Cancer Society.



Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Missouri Veterinary Medical Association
  • 0.50 Hours -
    Exam Attempts: 3
    -
    Exam Pass Rate: 50

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error